AFYA Stock: Price, Forecast, Financials & AI Analysis

High

Open

VWAP

Vol

Mkt Cap

Low

Amount

EV/EBITDA(TTM)

Total Shares

EV/OCF(TTM)

P/S(TTM)

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2025Q4

FY2026Q1

FY2026Q2

924.27M

+8.86%

1.944

-7.43%

1.01B

+7.37%

3.108

-2.88%

986.26M

+7.27%

2.260

-0.45%

Estimates Revision

The market is revising Downward the revenue expectations for Afya Limited (AFYA) for FY2025, with the revenue forecasts being adjusted by -0.01% over the past three months. During the same period, the stock price has changed by -7.53%.

Revenue Estimates for FY2025

Revise Downward

-0.01%

In Past 3 Month

EPS Estimates for FY2025

Revise Downward

-1.78%

In Past 3 Month

Stock Price

Go Down

-7.53%

In Past 3 Month

4 Analyst Rating

Wall Street analysts forecast AFYA stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for AFYA is 20.33 USD with a low forecast of 17.50 USD and a high forecast of 24.50 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

3 Buy

1 Hold

0 Sell

Strong Buy

Current: 14.490

Low

17.50

Averages

20.33

High

24.50

Current: 14.490

Low

17.50

Averages

20.33

High

24.50

BofA

Buy

downgrade

$22

2025-12-09

Reason

BofA

Price Target

$22

2025-12-09

downgrade

Buy

Reason

BofA lowered the firm's price target on Afya to $22 from $25.50 and keeps a Buy rating on the shares after updating the firm's estimates to incorporate a more conservative scenario on potential seats additions on already existing courses, while highlighting that the firm expects gross tuition to continue growing in line with inflation in 2026.

JPMorgan

Neutral -> Overweight

upgrade

2025-09-08

Reason

JPMorgan

Price Target

2025-09-08

upgrade

Neutral -> Overweight

Reason

JPMorgan upgraded Afya to Overweight from Neutral with a price target of $24.50, up from $23.50. The company's focus on medical education ?provides superior consistency and visibility," the analyst tells investors in a research note. The firm says Afya is one of the most consistent players in the Brazilian education industry, with high visibility and never missing guidance. It views the stock as a "solid pick for the risk-averse."

UBS

Andre Salles

Neutral -> Buy

upgrade

$19

2025-09-08

Reason

UBS

Andre Salles

Price Target

$19

2025-09-08

upgrade

Neutral -> Buy

Reason

UBS analyst Andre Salles upgraded Afya to Buy from Neutral with a price target of $19, down from $19.50. JPMorgan also upgrade the stock this morning. UBS sees "strong momentum" for the company's business, with "healthy" demand for medical courses. Meanwhile, Afya's cost cutting initiatives should maintain its EBITDA margin at a fairly stable 45%, the analyst tells investors in a research note. The firm believes current share levels offer an opportunity to buy a "high quality, low leveraged and high return name" in the Brazil education industry.

Morgan Stanley

Underweight -> Equal Weight

upgrade

$19

2025-08-05

Reason

Morgan Stanley

Price Target

$19

2025-08-05

upgrade

Underweight -> Equal Weight

Reason

Morgan Stanley upgraded Afya to Equal Weight from Underweight with a price target of $17.50, down from $19, as part of a broader research note on Brazil Education Services. The new sector regulation will both reshape industry structure and reset economic equilibrium, the analyst tells investors in a research note. Despite long-term medical school risks, the firm sees strong short-term earnings and a narrower valuation gap relative to peers, Morgan Stanley added.

Citi

Sell -> Neutral

upgrade

$16 -> $14

2025-07-29

Reason

Citi

Price Target

$16 -> $14

2025-07-29

upgrade

Sell -> Neutral

Reason

Citi upgraded Afya to Neutral from Sell with a price target of $14, down from $16. The firm says the company's risks are better priced into the shares following Afya's underperformance year-to-date relative to its Brazilian peers. The firm cites valuation for the upgrade despite dropping the target on reduced earnings assumptions.

UBS

Neutral

maintain

2025-06-12

Reason

UBS

Price Target

2025-06-12

maintain

Neutral

Reason

UBS raised the firm's price target on Afya to $19.50 from $17.50 and keeps a Neutral rating on the shares. Positive momentum on growth and margins seems fairly priced in, the analyst tells investors in a research note.

Valuation Metrics

The current forward P/E ratio for Afya Ltd (AFYA.O) is 8.05, compared to its 5-year average forward P/E of 14.06. For a more detailed relative valuation and DCF analysis to assess Afya Ltd 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

5Y Average PE

14.06

Current PE

8.05

Overvalued PE

20.01

Undervalued PE

8.12

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

5Y Average EV/EBITDA

8.51

Current EV/EBITDA

5.17

Overvalued EV/EBITDA

11.59

Undervalued EV/EBITDA

5.42

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

5Y Average PS

3.07

Current PS

1.82

Overvalued PS

4.60

Undervalued PS

1.55

Financials

Annual

Quarterly

N/A

Total Revenue

N/A

Operating Profit

N/A

Net Income after Tax

N/A

EPS - Diluted

N/A

Free Cash Flow

N/A

Gross Profit Margin - %

N/A

FCF Margin - %

N/A

Net Margin - %

N/A

ROIC

Trading Trends

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Hedge Fund

Hedge Funds are Neutral. There are no significant trading trends over the last quarter.

Sold

Bought

Congress Trading

Congress are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

AFYA News & Events

Events Timeline

No data

News

9.5

11-13NASDAQ.COM

Afya (AFYA) Exceeds Earnings Expectations in Q3

9.5

11-12Yahoo Finance

Afya Limited Reports Financial Results for Q3 and First Nine Months of 2025

5.0

11-07Newsfilter

Afya Limited Reveals Expansion of Medical Seats at AFYA Faculdade de Ciências Médicas Bragança

People Also Watch

Frequently Asked Questions

What is Afya Ltd (AFYA) stock price today?

The current price of AFYA is 14.49 USD — it has decreased -0.41 % in the last trading day.

What is Afya Ltd (AFYA)'s business?

Afya Ltd is a Brazil-based company engaged in the education sector. The Company is mainly focused on operating medical schools, offering health sciences courses, which comprise medicine, dentistry, nursing, radiology, psychology, pharmacy, physical education, physiotherapy, nutrition and biomedicine. In addition, the Firm provides degree programs and courses in other subjects and disciplines, including undergraduate and post graduate courses in business administration, accounting, law, civil engineering, industrial engineering and pedagogy. The Company's methodological approach combines integrated content, interactive learning, and an adaptive experience for learners. Through its educational content and technology-enabled activities, the Company focuses on personalized learning that mirrors one-on-one tutoring. The Company's undergraduate and graduate campuses are spread across Brazil, as well as its digital medical platform.

What is the price predicton of AFYA Stock?

What is Afya Ltd (AFYA)'s revenue for the last quarter?

Afya Ltd revenue for the last quarter amounts to 928.51M USD, increased 10.38 % YoY.

What is Afya Ltd (AFYA)'s earnings per share (EPS) for the last quarter?

Afya Ltd. EPS for the last quarter amounts to 1.70 USD, increased 29.77 % YoY.

What changes have occurred in the market's expectations for Afya Ltd (AFYA)'s fundamentals?

How many employees does Afya Ltd (AFYA). have?

Afya Ltd (AFYA) has 9717 emplpoyees as of December 15 2025.

What is Afya Ltd (AFYA) market cap?

Today AFYA has the market capitalization of 1.36B USD.